Liraglutida CAS: 204656-20-2

Product Detail

Composition:

Appearance: white crystalline powder

Assay: 99%

CAS: 204656-20-2

Packing: Bag

Shelf Life: 3 years

Storage: Store in cool and dry place

Certification: ISO

Technical Documents: HPLC GC NMR

Introduction: Liraglutide is a transparent, colorless solution. The dosage form is subcutaneous injection. After more than 10 years of research and development, Liraglutide has many effects, including promoting pancreatic cell regeneration, lowering blood sugar, reducing weight, and protecting the cardiovascular system. Use drugs to treat type 2 diabetes and chronic obesity as a supplement to diet control and physical exercise. Liraglutide is an acylated human glucagon like peptide-1 (GLP-1) receptor agonist with 97% amino acid sequence homology with endogenous human GLP-1 (7-37), retaining all the biological activity of GLP-1 and exhibiting GLP-1 receptor agonist activity.

Our Key Technology:

Liraglutida, diabetes, pharmaceutical intermediates